Novartis AG (NVS)
153.81
+2.69
(+1.78%)
USD |
NYSE |
Oct 26, 16:00
153.80
0.00 (0.00%)
After-Hours: 20:00
Novartis Market Cap : 281.56B for Oct. 26, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 26, 2026 | 281.56B |
| October 23, 2026 | 276.63B |
| October 22, 2026 | 286.06B |
| October 21, 2026 | 281.78B |
| October 20, 2026 | 281.25B |
| October 19, 2026 | 274.95B |
| October 16, 2026 | 275.72B |
| October 15, 2026 | 275.28B |
| October 14, 2026 | 268.87B |
| October 13, 2026 | 260.69B |
| October 12, 2026 | 263.31B |
| October 09, 2026 | 263.14B |
| October 08, 2026 | 261.97B |
| October 07, 2026 | 262.28B |
| October 06, 2026 | 257.72B |
| October 05, 2026 | 257.98B |
| October 02, 2026 | 258.11B |
| October 01, 2026 | 258.20B |
| September 30, 2026 | 260.98B |
| September 29, 2026 | 266.73B |
| September 28, 2026 | 268.87B |
| September 25, 2026 | 266.27B |
| September 24, 2026 | 262.81B |
| September 23, 2026 | 261.24B |
| September 22, 2026 | 258.62B |
| Date | Value |
|---|---|
| September 21, 2026 | 258.07B |
| September 18, 2026 | 256.95B |
| September 17, 2026 | 257.96B |
| September 16, 2026 | 253.90B |
| September 15, 2026 | 253.75B |
| September 14, 2026 | 254.43B |
| September 11, 2026 | 251.08B |
| September 10, 2026 | 251.66B |
| September 09, 2026 | 251.66B |
| September 08, 2026 | 252.07B |
| September 04, 2026 | 292.87B |
| September 03, 2026 | 298.54B |
| September 02, 2026 | 297.39B |
| September 01, 2026 | 295.18B |
| August 31, 2026 | 278.35B |
| August 28, 2026 | 281.56B |
| August 27, 2026 | 283.09B |
| August 26, 2026 | 288.38B |
| August 25, 2026 | 292.85B |
| August 24, 2026 | 289.26B |
| August 21, 2026 | 290.80B |
| August 20, 2026 | 286.00B |
| August 19, 2026 | 293.46B |
| August 18, 2026 | 282.91B |
| August 17, 2026 | 278.19B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Roche Holding AG | 331.13B |
| AstraZeneca PLC | 533.67B |
| GSK Plc | 103.36B |
| Johnson & Johnson | 641.02B |
| Eli Lilly & Co. | 1.204T |
Market Cap Related Metrics
| PE Ratio | 23.20 |
| PS Ratio | 5.403 |
| Price to Book Value | 6.778 |
| Price to Free Cash Flow | 19.75 |
| Price | 153.81 |
| Earnings Yield | 4.31% |
| Operating PE Ratio | 18.27 |
| Normalized PE Ratio | 21.62 |